Financhill
Sell
35

INTC Quote, Financials, Valuation and Earnings

Last price:
$19.78
Seasonality move :
11%
Day range:
$18.90 - $19.76
52-week range:
$18.51 - $51.28
Dividend yield:
2.56%
P/E ratio:
91.26x
P/S ratio:
1.54x
P/B ratio:
0.85x
Volume:
106.8M
Avg. volume:
76.5M
1-year change:
-57.34%
Market cap:
$84.2B
Revenue:
$54.2B
EPS (TTM):
-$3.72
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $72B $77.9B $79B $63.1B $54.2B
Revenue Growth (YoY) 1.58% 8.2% 1.49% -20.21% -14%
 
Cost of Revenues $29.8B $34.3B $35.2B $36.2B $32.5B
Gross Profit $42.1B $43.6B $43.8B $26.9B $21.7B
Gross Profit Margin 58.56% 56.01% 55.45% 42.61% 40.04%
 
R&D Expenses $13.4B $13.6B $15.2B $17.5B $16B
Selling, General & Admin $6.4B $6.2B $6.5B $7B $5.6B
Other Inc / (Exp) $1.1B $1.7B $103M $5.3B $102M
Operating Expenses $19.7B $19.7B $21.7B $24.5B $21.7B
Operating Income $22.4B $23.9B $22.1B $2.3B $31M
 
Net Interest Expenses -- $504M $482M -- --
EBT. Incl. Unusual Items $24.1B $25.1B $21.7B $7.8B $762M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3B $4.2B $1.8B -$249M -$913M
Net Income to Company $21B $20.9B $19.9B $8B $1.7B
 
Minority Interest in Earnings -- -- -- -$3M $14M
Net Income to Common Excl Extra Items $21B $20.9B $19.9B $8B $1.7B
 
Basic EPS (Cont. Ops) $4.77 $4.98 $4.89 $1.95 $0.40
Diluted EPS (Cont. Ops) $4.71 $4.94 $4.86 $1.94 $0.40
Weighted Average Basic Share $4.4B $4.2B $4.1B $4.1B $4.2B
Weighted Average Diluted Share $4.5B $4.2B $4.1B $4.1B $4.2B
 
EBITDA $35.4B $37.9B $34.1B $21.3B $11.2B
EBIT $24.5B $25.7B $22.3B $8.3B $1.6B
 
Revenue (Reported) $72B $77.9B $79B $63.1B $54.2B
Operating Income (Reported) $22.4B $23.9B $22.1B $2.3B $31M
Operating Income (Adjusted) $24.5B $25.7B $22.3B $8.3B $1.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $18.3B $19.2B $15.3B $14.2B $13.3B
Revenue Growth (YoY) -4.47% 4.69% -20.08% -7.69% -6.17%
 
Cost of Revenues $8.6B $8.4B $8.8B $8.1B $11.3B
Gross Profit $9.7B $10.7B $6.5B $6B $2B
Gross Profit Margin 53.13% 55.99% 42.61% 42.51% 15.03%
 
R&D Expenses $3.3B $3.8B $4.3B $3.9B $4B
Selling, General & Admin $1.4B $1.7B $1.7B $1.3B $1.4B
Other Inc / (Exp) $81M $1.7B -$815M -$1B -$5.8B
Operating Expenses $4.7B $5.5B $6B $5.2B $5.4B
Operating Income $5B $5.3B $489M $808M -$3.4B
 
Net Interest Expenses $74M $76M -- -- --
EBT. Incl. Unusual Items $5B $6.9B -$188M -$52M -$9.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $765M $35M -$1.2B -$362M $7.9B
Net Income to Company $4.3B $6.8B $1B $310M -$17B
 
Minority Interest in Earnings -- -- -- -$13M $350M
Net Income to Common Excl Extra Items $4.3B $6.8B $1B $297M -$16.6B
 
Basic EPS (Cont. Ops) $1.02 $1.68 $0.25 $0.07 -$3.88
Diluted EPS (Cont. Ops) $1.02 $1.67 $0.25 $0.07 -$3.88
Weighted Average Basic Share $4.2B $4.1B $4.1B $4.2B $4.3B
Weighted Average Diluted Share $4.2B $4.1B $4.1B $4.2B $4.3B
 
EBITDA $8.3B $10B $3.2B $2.6B -$5.2B
EBIT $5.2B $7B -$74M $152M -$8.8B
 
Revenue (Reported) $18.3B $19.2B $15.3B $14.2B $13.3B
Operating Income (Reported) $5B $5.3B $489M $808M -$3.4B
Operating Income (Adjusted) $5.2B $7B -$74M $152M -$8.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $78.1B $78.5B $69.5B $52.9B $54.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $34B $34.3B $37.2B $32.7B $35.4B
Gross Profit $44.1B $44.2B $32.4B $20.2B $18.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $13.3B $14.8B $17.1B $16.5B $16.7B
Selling, General & Admin $6B $6.4B $7.2B $5.7B $5.9B
Other Inc / (Exp) $578M $1.4B $6B -$1.4B -$5.8B
Operating Expenses $19.3B $21.2B $24.4B $22.2B $22.5B
Operating Income $24.8B $23B $8B -$2.1B -$3.7B
 
Net Interest Expenses -- $416M $238M -- --
EBT. Incl. Unusual Items $25.7B $24B $13.8B -$2.8B -$9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.7B $2.9B $457M -$1.2B $7.4B
Net Income to Company $21.9B $21.1B $13.3B -$1.6B -$16.4B
 
Minority Interest in Earnings -- -- -- $2M $459M
Net Income to Common Excl Extra Items $21.9B $21.1B $13.3B -$1.6B -$16B
 
Basic EPS (Cont. Ops) $5.15 $5.19 $3.27 -$0.40 -$3.72
Diluted EPS (Cont. Ops) $5.10 $5.15 $3.25 -$0.40 -$3.72
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $38.5B $36.3B $27.1B $8.3B $3.3B
EBIT $26.2B $24.6B $14.2B -$2.1B -$8B
 
Revenue (Reported) $78.1B $78.5B $69.5B $52.9B $54.2B
Operating Income (Reported) $24.8B $23B $8B -$2.1B -$3.7B
Operating Income (Adjusted) $26.2B $24.6B $14.2B -$2.1B -$8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $57.9B $58.5B $49B $38.8B $38.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $25.6B $25.7B $27.6B $24.2B $27.1B
Gross Profit $32.3B $32.8B $21.4B $14.7B $11.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $9.9B $11.1B $13.1B $12.1B $12.7B
Selling, General & Admin $4.4B $4.6B $5.3B $4B $4.3B
Other Inc / (Exp) $66M -$227M $5.6B -$1.1B -$7B
Operating Expenses $14.3B $15.7B $18.4B $16.1B $16.9B
Operating Income $17.9B $17.1B $3B -$1.4B -$5.2B
 
Net Interest Expenses $416M $328M $222M -- --
EBT. Incl. Unusual Items $17.6B $16.5B $8.6B -$2B -$11.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.5B $1.3B -$114M -$1B $7.3B
Net Income to Company $15B $15.2B $8.7B -$985M -$19.1B
 
Minority Interest in Earnings -- -- -- $5M $450M
Net Income to Common Excl Extra Items $15B $15.2B $8.7B -$980M -$18.6B
 
Basic EPS (Cont. Ops) $3.55 $3.76 $2.13 -$0.24 -$4.35
Diluted EPS (Cont. Ops) $3.52 $3.73 $2.12 -$0.24 -$4.35
Weighted Average Basic Share $12.7B $12.2B $12.3B $12.5B $12.8B
Weighted Average Diluted Share $12.8B $12.3B $12.3B $12.6B $12.8B
 
EBITDA $27.3B $25.7B $18.7B $5.7B -$2.3B
EBIT $18.1B $17B $8.9B -$1.4B -$11B
 
Revenue (Reported) $57.9B $58.5B $49B $38.8B $38.8B
Operating Income (Reported) $17.9B $17.1B $3B -$1.4B -$5.2B
Operating Income (Adjusted) $18.1B $17B $8.9B -$1.4B -$11B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $4.2B $5.9B $4.8B $11.1B $7.1B
Short Term Investments $8.9B $18B $24.4B $17.2B $18B
Accounts Receivable, Net $7.7B $6.8B $9.5B $4.1B $3.4B
Inventory $8.7B $8.4B $10.8B $13.2B $11.1B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.7B $2.7B $2.1B $4.7B $3.7B
Total Current Assets $31.2B $47.2B $58.6B $50.4B $43.3B
 
Property Plant And Equipment $57B $56.6B $63.2B $80.9B $96.6B
Long-Term Investments $7.2B $7.3B $6.3B $5.9B $5.8B
Goodwill $26.3B $27B $27B $27.6B $27.6B
Other Intangibles $10.8B $9B $7.3B $6B $4.6B
Other Long-Term Assets $2B $5.9B $6.1B $11.3B $13.6B
Total Assets $136.5B $153.1B $168.4B $182.1B $191.6B
 
Accounts Payable $4.1B $5.6B $5.7B $9.6B $8.6B
Accrued Expenses $7.7B $8.2B $7.7B $9.5B $9.5B
Current Portion Of Long-Term Debt $3.7B $2.5B $4.6B $423M $2.3B
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $846M $2B $991M $44M -$12M
Total Current Liabilities $22.3B $24.8B $27.5B $32.2B $28.1B
 
Long-Term Debt $25.3B $33.9B $33.5B $37.7B $47B
Capital Leases -- -- -- -- --
Total Liabilities $59B $72.1B $73B $78.8B $81.6B
 
Common Stock $25.3B $25.6B $28B $31.6B $36.6B
Other Common Equity Adj -$1.3B -$751M -$880M -$562M -$215M
Common Equity $77.5B $81B $95.4B $101.4B $105.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- $1.9B $4.4B
Total Equity $77.5B $81B $95.4B $103.3B $110B
 
Total Liabilities and Equity $136.5B $153.1B $168.4B $182.1B $191.6B
Cash and Short Terms $13.1B $23.9B $29.3B $28.3B $25B
Total Debt $29B $36.4B $38.1B $42B $49.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $3.4B $7.9B $4.5B $7.6B $8.8B
Short Term Investments $14.9B $26.8B $18B $17.4B $15.3B
Accounts Receivable, Net $7.1B $8.4B $7.5B $2.8B $3.1B
Inventory $9.3B $9.8B $12.8B $11.5B $12.1B
Prepaid Expenses -- -- -- -- --
Other Current Assets $2.1B $2.1B $6.3B $4.5B $6.9B
Total Current Assets $36.8B $61.3B $49.3B $43.8B $46.1B
 
Property Plant And Equipment $59.2B $59.7B $75.8B $93.4B $104.2B
Long-Term Investments $6.4B $7B $5.8B $5.7B $5.5B
Goodwill $27B $26.8B $27.6B $27.6B $24.7B
Other Intangibles $9.9B $7.7B $6.3B $5B $4B
Other Long-Term Assets $6B $5.5B $10.1B $13.4B $9B
Total Assets $145.3B $168B $174.8B $188.8B $193.5B
 
Accounts Payable $5.2B $6.8B $7.1B $8.7B $11.1B
Accrued Expenses $13.3B $14.1B $15B $9.8B $9.7B
Current Portion Of Long-Term Debt -- $4.7B -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $22.1B $29.6B $27.8B $28.6B $35.2B
 
Long-Term Debt $36.1B $35.6B $37.2B $46.6B $46.5B
Capital Leases -- -- -- -- --
Total Liabilities $70.7B $77.9B $75B $83.2B $88.7B
 
Common Stock $23.3B $27.6B $30.9B $35.7B $50.7B
Other Common Equity Adj -$940M -$1.1B -$2.1B -$861M -$185M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- $3.9B $5.3B
Total Equity $74.6B $90.1B $99.9B $105.7B $104.9B
 
Total Liabilities and Equity $145.3B $168B $174.8B $188.8B $193.5B
Cash and Short Terms $18.3B $34.6B $22.6B $25B $24.1B
Total Debt $36.6B $40.3B $39.5B $48.9B $50.2B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $21B $20.9B $19.9B $8B $1.7B
Depreciation & Amoritzation $10.8B $12.2B $11.8B $13B $9.6B
Stock-Based Compensation $1.7B $1.9B $2B $3.1B $3.2B
Change in Accounts Receivable -$935M $883M -$2.7B $5.3B $731M
Change in Inventories -$1.5B -$687M -$2.3B -$2.4B $2.1B
Cash From Operations $33.1B $35.9B $29.5B $15.4B $11.5B
 
Capital Expenditures $16.2B $14.5B $20.3B $25.1B $25.8B
Cash Acquisitions -$2B $123M -- $6.6B --
Cash From Investing -$14.4B -$21.5B -$24.3B -$10.2B -$24B
 
Dividends Paid (Ex Special Dividend) -$5.6B -$5.6B -$5.6B -$6B -$3.1B
Special Dividend Paid
Long-Term Debt Issued $3.4B $10.2B $5B $10.5B $11.4B
Long-Term Debt Repaid -$2.6B -$4.5B -$2.5B -$5.3B -$4.5B
Repurchase of Common Stock -$13.6B -$14.2B -$2.4B -- --
Other Financing Activities $72M $509M -$1.6B $971M $3.6B
Cash From Financing -$17.6B -$12.7B -$6.2B $1.1B $8.5B
 
Beginning Cash (CF) $3B $4.2B $5.9B $4.8B $11.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.2B $1.7B -$1B $6.3B -$4.1B
Ending Cash (CF) $4.2B $5.9B $4.8B $11.1B $7.1B
 
Levered Free Cash Flow $16.9B $21.4B $9.1B -$9.6B -$14.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $4.3B $6.8B $1B $310M -$17B
Depreciation & Amoritzation $3.1B $3B $3.3B $2.4B $3.6B
Stock-Based Compensation $452M $543M $793M $772M $800M
Change in Accounts Receivable $301M -$940M -$1.4B $153M $10M
Change in Inventories -$299M -$1.1B -$657M $518M -$853M
Cash From Operations $8.2B $9.9B $1B $5.8B $4.1B
 
Capital Expenditures $3.7B $4.4B $7.3B $5.8B $6.5B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$766M -$10.6B -$4.6B -$7.4B -$2.8B
 
Dividends Paid (Ex Special Dividend) -$1.4B -$1.4B -$1.5B -$525M -$536M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $5B $6.1B $423M $1.5B
Long-Term Debt Repaid -$1.8B -- -$1.4B -$423M -$4.7B
Repurchase of Common Stock -$10B -- -- -- --
Other Financing Activities -$24M -$142M $521M $995M -$416M
Cash From Financing -$12.8B $3.8B $3.7B $842M -$3.8B
 
Beginning Cash (CF) $8.7B $4.7B $4.4B $8.3B $11.3B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$5.4B $3.1B $139M -$728M -$2.5B
Ending Cash (CF) $3.4B $7.9B $4.5B $7.6B $8.8B
 
Levered Free Cash Flow $4.5B $5.5B -$6.3B $71M -$2.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $21.9B $21.1B $13.3B -$1.6B -$16.4B
Depreciation & Amoritzation $12.2B $11.7B $12.8B $10.4B $11.2B
Stock-Based Compensation $1.8B $2B $2.8B $3.2B $3.6B
Change in Accounts Receivable -$254M -$1.3B $935M $4.6B -$277M
Change in Inventories -$675M -$1.3B -$3.2B $1.4B -$630M
Cash From Operations $35.4B $34.4B $13.1B $14.6B $9.7B
 
Capital Expenditures $15.1B $16.8B $26.8B $25B $24.8B
Cash Acquisitions -- -- $6.6B -- --
Cash From Investing -$19.6B -$26B -$11.7B -$22B -$19.8B
 
Dividends Paid (Ex Special Dividend) -$5.6B -$5.6B -$5.9B -$4.1B -$2.1B
Special Dividend Paid
Long-Term Debt Issued $13B -- $6.1B $15.8B $10.3B
Long-Term Debt Repaid -$5.7B -$500M -$5.4B -$6.4B -$9.6B
Repurchase of Common Stock -$17.7B -$2.4B -- -- --
Other Financing Activities -$412M -$1.4B $479M $3.1B $11.7B
Cash From Financing -$16.4B -$4B -$4.7B $10.5B $11.2B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$579M $4.5B -$3.3B $3.1B $1.2B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $20.3B $17.7B -$13.6B -$10.4B -$15.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $15B $15.2B $8.7B -$985M -$19.1B
Depreciation & Amoritzation $9.2B $8.7B $9.7B $7.1B $8.7B
Stock-Based Compensation $1.4B $1.6B $2.4B $2.4B $2.8B
Change in Accounts Receivable $525M -$1.6B $2B $1.3B $282M
Change in Inventories -$570M -$1.2B -$2B $1.8B -$969M
Cash From Operations $25.5B $24.1B $7.7B $6.8B $5.1B
 
Capital Expenditures $10.4B $12.7B $19.1B $19.1B $18.1B
Cash Acquisitions -- -- $6.6B -- --
Cash From Investing -$15.1B -$19.5B -$7B -$18.7B -$14.5B
 
Dividends Paid (Ex Special Dividend) -$4.2B -$4.2B -$4.5B -$2.6B -$1.6B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $10.2B $5B $6.1B $11.4B $10.3B
Long-Term Debt Repaid -$4.5B -$500M -$3.4B -$4.5B -$9.6B
Repurchase of Common Stock -$14.2B -$2.4B -- -- --
Other Financing Activities $605M -$1.3B $776M $2.9B $11B
Cash From Financing -$11.2B -$2.5B -$1B $8.4B $11.1B
 
Beginning Cash (CF) $24.3B $15.8B $15.4B $27.7B $25.3B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$838M $2B -$298M -$3.5B $1.7B
Ending Cash (CF) $23.5B $17.8B $15.1B $24.2B $27B
 
Levered Free Cash Flow $15.1B $11.4B -$11.4B -$12.2B -$13B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 3.14% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 2.61% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock